Catherine Bor-Angelier, MD

Dr. Catherine Bor-Angelier joined Labcorp Drug Development in 2020. Prior to joining Labcorp, she was head of the pathology department in a French cancer center. Catherine led a European research program on breast cancer heterogeneity using mathematic tools. She has extensive experience in anatomic pathology of the breast, in gynecology and gastroenterology oncologic pathology, as well as molecular and integrative pathology. In her current role, she is a lead anatomic pathologist and medical director at one of Labcorp’s central laboratory locations.

Catherine received her medical diplomas in France, in anatomic pathology, molecular pathology, breast oncology and general oncology.